Traws Pharma, Inc.
TRAW · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$54,674 | -$18,948 | -$18,964 | -$16,163 |
| Dep. & Amort. | $12 | $16 | $14 | $14 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$6,573 | -$301 | $1,484 | -$3,593 |
| Other Non-Cash | $31,443 | $1,301 | $1,172 | $255 |
| Operating Cash Flow | -$29,792 | -$17,932 | -$16,294 | -$19,487 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$14 | $0 | $0 |
| Net Acquisitions | -$3,648 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3,648 | -$14 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $33,976 | $0 | $0 | $55,041 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $519 |
| Financing Cash Flow | $33,976 | $0 | $0 | $55,560 |
| Forex Effect | -$19 | $10 | -$19 | -$28 |
| Net Chg. in Cash | $517 | -$17,936 | -$16,313 | $36,045 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,821 | $38,757 | $55,070 | $19,025 |
| End Cash | $21,338 | $20,821 | $38,757 | $55,070 |
| Free Cash Flow | -$29,792 | -$17,946 | -$16,294 | -$19,487 |